
Languages Spoken: English
Dr. Couriel received his M.D. degree in 1987 at the Universidad de Buenos Aires in Argentina. After fellowship training at Tufts University, NHLBI and Johns Hopkins University, he was appointed as Assistant Professor of Medicine at the University of Alabama Birmingham. In 1999 he moved to the M.D Anderson Cancer Center in the Department of Blood and Marrow Transplantation. He was promoted to Associate Professor in 2005, and in 2010 relocated to the Sarah Cannon Blood and Marrow Transplant Program in Nashville, TN where he was appointed as Director of the Allogeneic Transplant Program. In 2010 he moved to the University of Michigan Medical School where he served as Clinical Professor and Director of the Adult Blood and Marrow Transplantation Program. Dr. Couriel has a history of consistent funding and has more than 100 peer reviewed journal articles. His research interests are associated with new treatments and biomarkers for acute and chronic graft-versus-host disease. He serves on the Editorial Board of the Biology of Blood and Marrow Transplantation journal and in addition he co-chairs the GVHD subcommittee for the CIBMTR, and the Ancillary and Supportive Care committee of a NIH Consensus Project on Chronic GVHD.
Board Certification and Academic Information
Academic Departments | Internal Medicine
-
Professor |
Academic Divisions | Hematology/BMT |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5

Care provider's explanation of condition/problem
4.7/ 5

Care provider's effort to include me in decisions
4.8/ 5

Wait time at clinic
4.4/ 5

Care provider's concern for questions & worries
4.7/ 5

Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
February 19, 2022
HUNTSMAN CANCER CENTER
Andrea shindler is an excellent doctor
UofU Patient
October 11, 2021
HUNTSMAN CANCER CENTER
The proposed procedures frightened [NAME REMOVED] and those fears were not properly addressed.
UofU Patient
June 28, 2021
HUNTSMAN CANCER CENTER
Dr. Couriel is amazing.
UofU Patient
May 29, 2021
HUNTSMAN CANCER CENTER
so thorough. answered all my questions. helped me to feel hopeful about my cancer. referred me to a dr he had confidence in.
UofU Patient
May 15, 2021
HUNTSMAN CANCER CENTER
Dr Couriel is just awesome. he, the donor and the Good Lord saved my life. thank you
UofU Patient
April 19, 2021
HUNTSMAN CANCER CENTER
good
UofU Patient
April 09, 2021
HUNTSMAN CANCER CENTER
I usually refer to Dr. Couriel as my Hero. Though out my cancer treatment his care gave me the highest level of confidence in my outcome. He was always my advocate.
UofU Patient
March 26, 2021
HUNTSMAN CANCER CENTER
I know i am in good hands and that they are very professional and always willing to listen
UofU Patient
March 13, 2021
HUNTSMAN CANCER CENTER
very knowledgable and open to discussion
UofU Patient
January 16, 2021
HUNTSMAN CANCER CENTER
very good
UofU Patient
January 07, 2021
HUNTSMAN CANCER CENTER
none
UofU Patient
January 02, 2021
HUNTSMAN CANCER CENTER
good
UofU Patient
December 26, 2020
HUNTSMAN CANCER CENTER
Dr. Couriel is an exceptional provider.
UofU Patient
December 05, 2020
HUNTSMAN CANCER CENTER
amazing staff
UofU Patient
November 07, 2020
HUNTSMAN CANCER CENTER
Dr. Couriel spent extra time with me helping feel better regarding the PET scan that had just come back. I feel that he cares very much for my health and the best possible outcome.
UofU Patient
October 16, 2020
HUNTSMAN CANCER CENTER
Dr Couriel is why I am alive
UofU Patient
October 13, 2020
HUNTSMAN CANCER CENTER
good experience
UofU Patient
September 06, 2020
HUNTSMAN CANCER CENTER
Dr Couriel is a great doctor. he is the reason I am doing well.
UofU Patient
August 09, 2020
HUNTSMAN CANCER CENTER
the care provider and Dr Couriel do an excellent job. I am alive because of Huntsman and Dr Couriel!!!
UofU Patient
August 02, 2020
HUNTSMAN CANCER CENTER
Dr Couriel and all his staff are excellent!!!! I am so grateful to ALL of them!!!!
UofU Patient
July 05, 2020
HUNTSMAN CANCER CENTER
last visit
UofU Patient
June 22, 2020
HUNTSMAN CANCER CENTER
he was falling asleep. seemed really tired. very unprofessional
Dr. Couriel received his M.D. degree in 1987 at the Universidad de Buenos Aires in Argentina. After fellowship training at Tufts University, NHLBI and Johns Hopkins University, he was appointed as Assistant Professor of Medicine at the University of Alabama Birmingham. In 1999 he moved to the M.D Anderson Cancer Center in the Department of Blood and Marrow Transplantation. He was promoted to Associate Professor in 2005, and in 2010 relocated to the Sarah Cannon Blood and Marrow Transplant Program in Nashville, TN where he was appointed as Director of the Allogeneic Transplant Program. In 2010 he moved to the University of Michigan Medical School where he served as Clinical Professor and Director of the Adult Blood and Marrow Transplantation Program. Dr. Couriel has a history of consistent funding and has more than 100 peer reviewed journal articles. His research interests are associated with new treatments and biomarkers for acute and chronic graft-versus-host disease. He serves on the Editorial Board of the Biology of Blood and Marrow Transplantation journal and in addition he co-chairs the GVHD subcommittee for the CIBMTR, and the Ancillary and Supportive Care committee of a NIH Consensus Project on Chronic GVHD.
Academic Locations
Board Certification and Academic Information
Academic Departments | Internal Medicine
-
Professor |
Academic Divisions | Hematology/BMT |
Research Interests
- New Treatments for Acute Graft-Versus Host Disease
- Biomarkers and New Treatments for Chronic Graft-Versus Host Disease
- Ancillary and Supportive Care for Chronic Graft-Versus-Host Disease
- Long Term Complications and Survivorship Issues after Allogeneic Stem Cell Transplantation
- Multidisciplinary Interventions and Patient Reported Outcomes in the Assessment of Response to Therapy in Chronic Graft-Versus Host Disease
Education History
Graduate Training | University of Michigan School of Public Health Biostatistics and Clinical Research M.Med.Sci., 2012 |
Residency | George Washington University Hospital Internal Medicine Resident, 1997 |
Fellowship | National Heart, Lung, and Blood Institute Hematology Fellow, 1994 |
Fellowship | Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine Bone Marrow Transplantation Unit Fellow, 1994 |
Fellowship | Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine Leukemia Unit Fellow, 1993 |
Fellowship | St. Elizabeth’s Medical Center, Tufts University School of Medicine Hematology/Oncology Fellow, 1993 |
Residency | University of Buenos Aires Internal Medicine Resident, 1991 |
Professional Medical | University of Buenos Aires School of Medicine Medicine M.D., 1987 |
Graduate Training | University of Utah Eccles School of Business Business and Health Administration MBA, MHA, |
Selected Publications - Journal Articles
Journal Article
- DePriest BP, Li H, Bidgoli A, Onstad L, Couriel DR, Lee SJ, Paczesny S (2022). Regenerating Islet-Derived 3-alpha is a Prognostic Biomarker for Gastrointestinal Chronic Graft-Versus-Host Disease. Blood Adv.
- Wolff D, Radojcic V, Lafyatis R, Cinar R, Rosenstein RK, Cowen EW, Cheng GS, Sheshadri A, Bergeron A, Williams KM, Todd JL, Teshima T, Cuvelier GDE, Holler E, McCurdy SR, Jenq RR, Hanash AM, Jacobsohn D, Santomasso BD, Jain S, Ogawa Y, Steven P, Luo ZK, Dietrich-Ntoukas T, Saban D, Bilic E, Penack O, Griffith LM, Cowden M, Martin PJ, Greinix HT, Sarantopoulos S, Socie G, Blazar BR, Pidala J, Kitko CL, Couriel DR, Cutler C, Schultz KR, Pavletic SZ, Lee SJ, Paczesny S (2021). National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. Transplant Cell Ther, 27(10), 817-835.
- DeFilipp Z, Couriel DR, Lazaryan A, Bhatt VR, Buxbaum NP, Alousi AM, Olivieri A, Pulanic D, Halter JP, Henderson LA, Zeiser R, Gooley TA, MacDonald KPA, Wolff D, Schultz KR, Paczesny S, Inamoto Y, Cutler CS, Kitko CL, Pidala JA, Lee SJ, Socie G, Sarantopoulos S, Pavletic SZ, Martin PJ, Blazar BR, Greinix HT (2021). National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report. Transplant Cell Ther, 27(9), 729-737.
- Mehta RS, Bassett R, Rondon G, Overman BJ, Popat UR, Hosing CM, Rezvani K, Qazilbash MH, Anderlini P, Jones RB, Kebriaei P, Marin D, Khouri IF, Oran B, Ciurea SO, Kondo K, Couriel DR, Shpall EJ, Champlin RE, Alousi AM (2021). Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD. Bone Marrow Transplant, 56(6), 1316-1324.
- Christensen A, Hsieh F, Boyer M, Couriel D, Reems JA (2020). Red Cell Depletion of Major ABO Incompatible Bone Marrow Hematopoietic Progenitor Cells HPC(M) with the Spectra Optia®. Ann Clin Lab Sci, 50(6), 781-789.
- Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Agrawal V, Ahmed I, Al-Homsi AS, Aljurf M, Antin JH, Askar M, Auletta JJ, Bhatt VR, Chee L, Chhabra S, Daly A, DeFilipp Z, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Hogan WJ, Inamoto Y, Martino R, Majhail NS, Marks DI, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Rangarajan HG, Ringden O, Saad A, Savani BN, Schoemans H, Seo S, Schultz KR, Solh M, Spitzer T, Storek J, Teshima T, Verdonck LF, Wirk B, Yared JA, Cahn JY, Weisdorf DJ (2020). Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT. J Clin Oncol, 38(18), 2062-2076.
- Saad A, de Lima M, Anand S, Bhatt VR, Bookout R, Chen G, Couriel D, Di Stasi A, El-Jawahri A, Giralt S, Gutman J, Ho V, Horwitz M, Hsu J, Juckett M, Kharfan-Dabaja MA, Loren A, Meade J, Mielcarek M, Moreira J, Nakamura R, Nieto Y, Roddy J, Satyanarayana G, Schroeder M, Tan CR, Tzachanis D, Burn J, Pluchino L (2020). Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 18(5), 599-634.
- Barnes CA, Stout NL, Varghese TK Jr, Ulrich CM, Couriel DR, Lee CJ, Noren CS, LaStayo PC (2019). Clinically Integrated Physical Therapist Practice in Cancer Care: A New Comprehensive Approach. Phys Ther, 100(3), 543-553.
- Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J, Gale RP, Gandhi M, Gergis U, Hamilton BK, Hematti P, Hildebrandt GC, Kamble RT, Kanate AS, Khandelwal P, Lazaryan A, MacMillan M, Marks DI, Martino R, Mehta PA, Nishihori T, Olsson RF, Patel SS, Qayed M, Rangarajan HG, Reshef R, Ringden O, Savani BN, Schouten HC, Schultz KR, Seo S, Shaffer BC, Solh M, Teshima T, Urbano-Ispizua A, Verdonck LF, Vij R, Waller EK, William B, Wirk B, Yared JA, Yu LC, Arora M, Hashmi S (2019). Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. Biol Blood Marrow Transplant, 25(9), 1875-1883.
- Hamilton BK, Liu Y, Hemmer MT, Majhail N, Ringden O, Kim D, Costa L, Stuart R, Alousi A, Pidala JA, Couriel DR, Aljurf M, Antin JH, Bredeson C, Cahn JY, Cairo M, Choi SW, Dandoy C, Gale RP, Gergis U, Hematti P, Inamoto Y, Kamble RT, MacMillan M, Marks DI, Nemecek E, Nishihori T, Saad A, Savani BN, Schriber J, Seo S, Soci G, Teshima T, Verdonck LF, Waller EK, Wirk M, Spellman SR, Arora M, Chhabra S (2019). Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant, 25(9), 1744-1755.
- DSouza A, Hari P, Pasquini M, Braun T, Johnson B, Lundy S, Couriel D, Hamadani M, Magenau J, Dhakal B, Shah NN, Riwes M, Parkin B, Reddy P, Pawarode A (2019). A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Biol Blood Marrow Transplant, 25(8), 1492-1497.
- Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Ahmed I, Aljurf M, Askar M, Auletta JJ, Bhatt V, Bredeson C, Chhabra S, Gadalla S, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Inamoto Y, Kitko C, Khandelwal P, MacMillan ML, Majhail N, Marks DI, Mehta P, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Qayed M, Rangarajan H, Ringden O, Saad A, Savani BN, Seo S, Shah A, Shah N, Schultz KR, Solh M, Spitzer T, Szer J, Teshima T, Verdonck LF, Williams KM, Wirk B, Wagner J, Yared JA, Weisdorf DJ (2018). GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. Blood Adv, 3(9), 1441-1449.
- Carpenter PA, Kitko CL, Elad S, Flowers ME, Gea-Banacloche JC, Halter JP, Hoodin F, Johnston L, Lawitschka A, McDonald GB, Opipari AW, Savani BN, Schultz KR, Smith SR, Syrjala KL, Treister N, Vogelsang GB, Williams KM, Pavletic SZ, Martin PJ, Lee SJ, Couriel DR (2015). National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant, 21(7), 1167-87.
- Abedin S, Yanik GA, Braun T, Pawarode A, Magenau J, Goldstein SC, Levine JE, Kitko CL, Couriel DR (2015). Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung. Biol Blood Marrow Transplant, 21(6), 1127-31.
- Radojcic V, Pletneva MA, Couriel DR (2015). The role of extracorporeal photopheresis in chronic graft-versus-host disease. Transfus Apher Sci, 52(2), 157-61.
- Abedin S, Peres E, Levine JE, Choi S, Yanik G, Couriel DR (2014). Double umbilical cord blood transplantation after novel myeloablative conditioning using a regimen of fludarabine, busulfan, and total lymphoid irradiation. Biol Blood Marrow Transplant, 20(12), 2062-6.
- Blazar B, White ES, Couriel D (2012). Understanding chronic GVHD from different angles. Biol Blood Marrow Transplant, 18(1 Suppl), S184-8.
- Saliba RM, Couriel DR, Giralt S, Rondon G, Okoroji GJ, Rashid A, Champlin RE, Alousi AM (2012). Prognostic value of response after upfront therapy for acute GVHD. Bone Marrow Transplant, 47(1), 125-31.
- Parmar S, Andersson BS, Couriel D, Munsell MF, Fernandez-Vina M, Jones RB, Shpall EJ, Popat U, Anderlini P, Giralt S, Alousi A, Cano P, Bosque D, Hosing C, Silva Lde P, Westmoreland M, Wathen JK, Berry D, Champlin RE, de Lima MJ (2011). Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study. J Clin Oncol, 29(3), 294-302.
- Westin JR, Saliba RM, De Lima M, Alousi A, Hosing C, Qazilbash MH, Khouri IF, Shpall EJ, Anderlini P, Rondon G, Andersson BS, Champlin R, Couriel DR (2011). Steroid-Refractory Acute GVHD: Predictors and Outcomes. Adv Hematol, 2011, 601953.
- Couriel DR, Saliba R, de Lima M, Giralt S, Andersson B, Khouri I, Hosing C, Ippoliti C, Shpall EJ, Champlin R, Alousi A (2009). A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant, 15(12), 1555-62.
- Knobler R, Barr ML, Couriel DR, Ferrara JL, French LE, Jaksch P, Reinisch W, Rook AH, Schwarz T, Greinix H (2009). Extracorporeal photopheresis: past, present, and future. J Am Acad Dermatol, 61(4), 652-65.
- Macmillan ML, Couriel D, Weisdorf DJ, Schwab G, Havrilla N, Fleming TR, Huang S, Roskos L, Slavin S, Shadduck RK, Dipersio J, Territo M, Pavletic S, Linker C, Heslop HE, Deeg HJ, Blazar BR (2007). A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease. Blood, 109(6), 2657-62.
- Hymes SR, Turner ML, Champlin RE, Couriel DR (2006). Cutaneous manifestations of chronic graft-versus-host disease. Biol Blood Marrow Transplant, 12(11), 1101-13.
- Couriel DR, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B, Smith V, Khouri I, Giralt S, de Lima M, Hsu Y, Ghosh S, Neumann J, Andersson B, Qazilbash M, Hymes S, Kim S, Champlin R, Donato M (2006). Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood, 107(8), 3074-80.
- Couriel DR, Saliba R, Escalon MP, Hsu Y, Ghosh S, Ippoliti C, Hicks K, Donato M, Giralt S, Khouri IF, Hosing C, de Lima MJ, Andersson B, Neumann J, Champlin R (2005). Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol, 130(3), 409-17.
- Couriel D, Saliba R, Hicks K, Ippoliti C, de Lima M, Hosing C, Khouri I, Andersson B, Gajewski J, Donato M, Anderlini P, Kontoyiannis DP, Cohen A, Martin T, Giralt S, Champlin R (2004). Tumor necrosis factor-alpha blockade for the treatment of acute GVHD. Blood, 104(3), 649-54.
- Couriel D, Canosa J, Engler H, Collins A, Dunbar C, Barrett AJ (1996). Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow Transplant, 18(2), 347-53.
Letter
- Trunk AD, Shewan SK, Lee CJ, Parker CJ, Couriel DR (2022). Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination. [Letter to the editor]. Bone Marrow Transplant, 57(3), 502-503.
- Trunk AD, Shewan SK, Lee CJ, Parker CJ, Couriel DR (2022). Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination. [Letter to the editor]. Bone Marrow Transplant, 57(3), 502-503.
- Radojcic V, Pletneva M, Lee CJ, Ivcevic S, Sarantopoulos S, Couriel D (2021). Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease. [Letter to the editor]. Br J Haematol, 195(2), e120-e122.
Abstract
- Khouri IF, Saliba RM, Hosing C, Okoroji GJ, Acholonu S, Anderlini P, Couriel D, de Lima M, Donato ML, Fayad L, Giralt S, Jones R, Korbling M, Maadani F, Manning JT, Pro B, Shpall E, Youness A, McLaughlin P, Champlin RE (2002). Concurrent administration of high- dose rituximab (HD-R) with G/GM-CSF and autologous Stem cell Transplantation for relapsed B cell lymphomas: Increased efficacy without added toxicity [Abstract]. Blood, 100(11), 645a.
Global Impact
Education History
Residency | University of Buenos Aires Internal Medicine Resident |
Professional Medical | University of Buenos Aires School of Medicine Medicine M.D. |